/stocks — the workspaceLOADING
All MDWD SEC filings, by type → · Earnings date & implied move · Search inside filings
MediWound Ltd. (MDWD) is a medicinal chemicals & botanical products company. 2 insider Form 4 filings in the last 90 days. Fundamentals from SEC filings; prices are end-of-day.
What’s behind MDWD’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
End-of-day bars · delayed, not real-time · data: Databento · studies computed in your browser from these barsCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
No recent 10-K / 10-Q / 8-K filings found.
Has MDWD been issuing shares? Offering history →
Not reported in XBRL for this filer.
Not reported in XBRL for this filer.
Not reported in XBRL for this filer.
↓ Download the fiscal-year statement table: XLSX · CSV · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
As filed. We do not recategorize line items. Each chart plots one XBRL concept exactly as MDWD tagged it, period by period; a period the company did not tag on its own is left out, not estimated. A figure that disagrees with the filing is a bug in our extraction, not a policy, and we fix it: report a mismatch.
A plain-English read on MDWD plus an auto-SWOT — built from MDWD's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate MDWD using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Projected from MDWD's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentMDWD files or announces.
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
No lawmaker has disclosed a trade in MDWD under the STOCK Act.
No fair value band on this page build. No annual filing figures reached the estimators, either because the SEC read did not finish or because MDWD has not filed annual figures yet. That is a statement about the read, not about MDWD’s value. The page rebuilds daily.
Every refusal recorded for MDWD → · How often we decline, and why →
No tracked institution reported a position in MDWD in the latest 13F round.
Every registered fund files its complete portfolio with the SEC. These weights come from those filings, so each one carries the period it describes. Holdings are quarterly and filed in arrears — the figures below are as of 2026-06-30, not today.
| Fund | Weight | As of |
|---|---|---|
| IWM iShares Russell 2000 ETF | <0.01% | 2026-06-30 |
Drawn from 39 large US equity funds we scan, not every fund in existence, so a missing fund means we do not scan it rather than that it holds none. Holdings are joined to tickers by issuer name, which does not resolve every position; what that misses is published.
Of 2 sales in the last ~6 months, 0 were filed with the Rule 10b5-1 box checked, set up in advance under a written trading plan; 2 were filed without it.
| Rubinstein SamuelDirector | SELL | $7K | view → |
| Rubinstein SamuelDirector | BUY | $7K | view → |
| Hess ShmuelCOO & Chief Commercial Officer | SELL | $75K | view → |
| SHAMIR NACHUMDirector | BUY | $84K | view → |
| Fox David MortonDirector | BUY | $50K | view → |
| Rubinstein SamuelDirector | BUY | $2K | view → |
1 of the 2 checks that ran found nothing new for MDWD; 1 found something. 2 could not run.
Each event check looks back 30 days from the date its own source was stored, read or generated, never from the date this page was built. A check that finds nothing is a measurement of that window, not a forecast, and a check that cannot be dated does not make the claim at all.
From SEC Form 4 and 13F filings. Both are backward-looking disclosures on different reporting clocks, and neither predicts price. Educational information only — not investment advice.
Head office: Yavne, Israel · the company’s charter and its head office are in different countries.
EDGAR’s company directory says Israel. We show the company’s own most recent filing. The directory is a separate record, and the two can differ in either direction: a directory entry can change before the next filing shows a reincorporation, or go on showing a jurisdiction the company has left.
Source: the cover page of MediWound Ltd.’s 20-F filed 2026-03-05, on EDGAR. Filings checked 2026-10-26. Incorporation is where the company’s charter was filed. It is not where the business operates or earns, which no filing cover states. How this works